or Try an Advanced Search...

    Hematological Malignancies Stocks List

    Symbol Grade Name % Change
    ABBV A AbbVie Inc. -0.26
    CNTA B Centessa Pharmaceuticals plc 7.57
    TGTX C TG Therapeutics, Inc. -2.39
    ALRN D Aileron Therapeutics, Inc. 2.26
    PSTX D Poseida Therapeutics, Inc. -3.85
    SNDX F Syndax Pharmaceuticals, Inc. 3.32
    ADAP F Adaptimmune Therapeutics plc -3.05
    MRKR F Marker Therapeutics, Inc. -3.90
    CERO F CERo Therapeutics Holdings, Inc. 9.97
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Other
    Related Stock Lists: Cancer Solid Tumors Biopharmaceutical Immunotherapy Lymphoma Medicine Cancer Immunotherapy Cancer Treatment Clinical Medicine Immune System Treatment Of Cancer Tumor Virotherapy Adoptive Cell Transfer Cell Therapy Lung Cancer Non Small Cell Lung Cancer Oncogenes Ovarian Cancer Peptides

    Related ETFs - A few ETFs which own one or more of the above listed Hematological Malignancies stocks.

    Symbol Grade Name Weight
    BOTZ B Global X Robotics & Artificial Intelligence Thematic ETF 9.94
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    FDL A First Trust Morningstar ETF 8.37
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 8.1
    MEDX D Horizon Kinetics Medical ETF 7.89
    View all Hematological Malignancies ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare HDLB to FDL Compare HDLB to MEDX

        Hematological Malignancies Stocks Recent News

        Date Stock Title
        Oct 1 ABBV Should You Buy AbbVie Stock After Recent Parkinson's Study Success?
        Oct 1 ABBV AbbVie withdraws Exviera from EU market for commercial reasons
        Oct 1 ABBV AbbVie to Host Third-Quarter 2024 Earnings Conference Call
        Sep 30 ABBV AbbVie Inc. (ABBV) Projects Mid-Single-Digit Sales Growth Over Next 3 Years
        Sep 30 PSTX Poseida: Interim P-BCMA-ALLO1 Data Bodes Well For Phase 1B Advancement
        Sep 30 ABBV AbbVie Seeks Approval for Lung Cancer Candidate Teliso-V
        Sep 30 ABBV Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It?
        Sep 30 ABBV Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
        Sep 30 ABBV 15 Best Dividend Stocks for Lifelong Passive Income
        Sep 29 ABBV Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
        Sep 29 ABBV Is AbbVie Inc.'s (NYSE:ABBV) ROE Of 78% Impressive?
        Sep 29 ABBV AbbVie: Dividend Discount Model Suggests Large Valuation Risks
        Sep 27 PSTX Poseida struggles post market after phase 1 multiple myeloma CAR-T therapy data
        Sep 27 PSTX Poseida Therapeutics Reports Positive Interim Phase 1 Results for Allogeneic CAR-T Therapy P-BCMA-ALLO1 with High Overall Response Rates in Heavily Pretreated Relapsed/Refractory Multiple Myeloma Patients
        Sep 27 ABBV 15 Unhealthiest Countries in Latin America
        Sep 27 ABBV Bristol Cobenfy approval draws optimism from Street, though with caveats
        Sep 27 ABBV ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
        Sep 27 ABBV AbbVie submits BLA for antibody-drug conjugate Teliso-V for NSCLC
        Sep 27 ABBV AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer
        Sep 27 ABBV Bristol Myers Stock Up on FDA Nod for Schizophrenia Treatment
        Related Industries: Biotechnology Drug Manufacturers - Major Other
        Related Stock Lists: Cancer Solid Tumors Biopharmaceutical Immunotherapy Lymphoma Medicine Cancer Immunotherapy Cancer Treatment Clinical Medicine Immune System Treatment Of Cancer Tumor Virotherapy Adoptive Cell Transfer Cell Therapy Lung Cancer Non Small Cell Lung Cancer Oncogenes Ovarian Cancer Peptides
        Hematological Malignancies

        Hematological malignancies are cancers of the blood, bone marrow, and lymphatic system. These cancers can affect the production and function of blood cells, leading to a variety of symptoms and complications. Common types of hematological malignancies include leukemia, lymphoma, and multiple myeloma. Treatment for these cancers may include chemotherapy, radiation therapy, and/or stem cell transplantation.

        Browse All Tags